Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
|Articles|January 12, 2004
Special Report: Are controlled drugs out of control?
Why must pharmacists meet rigorous standards before they can dispense controlled substances when they are available indiscriminately over the Internet?
Advertisement
Advertisement
Related to this article
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Cheri Schmit explains how pharmacists' roles are growing beyond dispensing into prevention, test-and-treat, and artificial intelligence-supported patient care.
In celebration of American Pharmacists Month, Melissa McGivney, PharmD, FAPhA, FCCP, provides a snapshot of where the profession has come and where it still has to go.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Sara Hover, RPh, FAARM, explains how these products are putting pharmacists at the center of safety and evidence evaluations one patient at a time.
Independent pharmacies adapt to specialty drugs, biosimilars, cold-chain, and REMS demands.
During American Pharmacists Month, pharmacy teams reflect on their roles and explore ways to enhance patient care.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
2
FDA Approves Brytly for OTC Eye Redness Relief
3
Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026
4
American Pharmacists Month: Why It Matters More Than Ever
5